Prognostic Role of Human Leukocyte Antigen Alleles and Cytokine Single-Nucleotide Polymorphisms in Patients with Chronic Myeloid Leukemia Treated with …

SK Birru, I Doxiadis, R Howe, T Kelemu, SH Chala… - Genes, 2024 - mdpi.com
Tyrosine kinase inhibitor (TKI) drugs have significantly improved chronic myeloid leukemia
(CML) outcomes. Neopeptides from CML cells may induce specific immune responses …